Cargando…
Boosting Mouse Defense against Lethal Toxoplasma gondii Infection with Full-Length and Soluble SAG1 Recombinant Protein
Toxoplasmosis is a major worldwide protozoan zoonosis. The surface antigen 1 (SAG1) of Toxoplasma gondii (T. gondii) has always been recognized as an ideal vaccine candidate antigen. However, the intact and soluble SAG1 protein is usually difficult to acquire in vitro, which is unfavorable for emplo...
Autores principales: | Li, Xiang, Yuan, Wei, He, Ting, Guo, Ruiying, Du, Xiuxian, He, Yanhong, Li, Xuan, El-Ashram, Saeed, Al-Olayan, Ebtesam M., Yang, Na, Sang, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675489/ https://www.ncbi.nlm.nih.gov/pubmed/38006011 http://dx.doi.org/10.3390/vaccines11111678 |
Ejemplares similares
-
Co-Immunization with DNA Vaccines Expressing SABP1 and SAG1 Proteins Effectively Enhanced Mice Resistance to Toxoplasma gondii Acute Infection
por: Sang, Xiaoyu, et al.
Publicado: (2023) -
Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii
por: Wang, Yanhua, et al.
Publicado: (2014) -
Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1
por: Wang, Yanhua, et al.
Publicado: (2013) -
Toxoplasma gondii SAG1 targeting host cell S100A6 for parasite invasion and host immunity
por: Zhou, Li-Juan, et al.
Publicado: (2021) -
Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii
por: Lu, Gang, et al.
Publicado: (2014)